Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Concord Biotech has informed that the officials of the Company will be attending the Investor Conference on 25th February 2026 at 11:00 am onwards in Mumbai Organised by IIFL Capital (1x1 / Group Meeting). Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
